INSULET CORP (PODD)
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
Aeva to Showcase CityOS AI-Powered Traffic Intelligence Platform at ITS America 2026
BrilliA Incorporated Announces Jockey® Trademark License Agreement for Indonesia
Destination XL Group, Inc. Reports First Quarter Financial Results
Ollie’s Bargain Outlet Holdings, Inc. Announces First Quarter Fiscal 2026 Results
Emerita Announces Appointments of New Independent Director and Corporate Secretary
Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation